U.S. Beverage Stock News

Terns Pharmaceuticals recently attracted renewed attention after updating its corporate presentation with refreshed pipeline timelines and milestones, while also being selected for inclusion in a STOXX benchmark index effective March 23, 2026. This combination of clearer development visibility, impending index inclusion, and investor focus on the upcoming earnings update has sharpened debate around the company’s long-term prospects and current financial pressures. With investors now closely...

Context for Forestar Group after recent trading moves Forestar Group (FOR) has seen mixed share performance recently, with a 1 day gain of 1.6% contrasting with declines over the past week, month, and past 3 months, which may prompt investors to reassess the stock. See our latest analysis for Forestar Group. Zooming out, Forestar Group’s recent 1 day share price gain sits against a weaker patch, with a 30 day share price return of a 16.4% decline but a 3 year total shareholder return of...

MicroVision’s latest earnings draw investor focus MicroVision (MVIS) is back in the spotlight after reporting full year 2025 earnings, with sales of US$1.21 million compared with US$4.7 million a year earlier and a net loss of US$94.98 million. See our latest analysis for MicroVision. Despite the earnings update, MicroVision’s share price has faced pressure, with a 30 day share price return of 29.18% and a 1 year total shareholder return of 58.42%. This suggests momentum has been fading as...

Why ServiceTitan stock is back in focus ServiceTitan (TTAN) is drawing fresh attention after a busy set of March updates, including fourth quarter and full year results, new revenue guidance, and a leadership hire focused squarely on AI. See our latest analysis for ServiceTitan. ServiceTitan shares have been volatile around the recent earnings release and AI focused leadership appointment, with a 1 day share price return of 6.41% decline and a 7 day share price return of 14.65% decline. The...

On March 5, 2026, Popular, Inc. declared a monthly cash dividend of US$0.132813 per share on its 6.375% Non-Cumulative Monthly Income Preferred Stock, 2003 Series A, payable on March 31, 2026 to shareholders of record as of March 15, 2026, and earlier in the month its CEO presented at the RBC Capital Markets Global Financial Institutions Conference in New York. The combination of a continued preferred dividend payout and management’s public commentary on capital return, digital investments,...

In its latest quarterly update, ITT reported past revenues of US$1.05 billion, up 13.5% year on year and above analyst expectations, while also closing its acquisition of SPX FLOW and renaming its Industrial Process segment to Flow Technologies under new leadership. Together, the earnings surprise and SPX FLOW integration mark a significant broadening of ITT’s global flow technologies platform and shift in its business mix beyond purely organic growth. We’ll now examine how ITT’s revenue...

Bilibili Inc. has reported full-year 2025 results, with sales rising to CNY 6,394.64 million and total revenue reaching CNY 30,347.77 million, while net income improved to CNY 1,193.53 million compared with a net loss in the prior year. The shift from a loss per share to basic earnings per share of CNY 2.85 from continuing operations marks a clear return to profitability that reshapes how investors may view the platform’s underlying business quality. We will now examine how Bilibili’s return...

If you are wondering whether Incyte at around US$92.54 is offering good value or asking too much, you are not alone. This article is written for that exact question. The share price has seen mixed moves, with a 3.5% decline over the last 7 days and an 8.5% decline over the past month, alongside longer term returns of 36.4% over 1 year, 25.7% over 3 years and 16.6% over 5 years. Recent attention on Incyte has been shaped by ongoing product and pipeline updates, regulatory milestones and...

In March 2026, Codexis reported fourth-quarter 2025 results showing revenue of US$38.92 million and net income of US$9.6 million, reversing a prior-year loss and beating analyst expectations, alongside full-year 2025 revenue of US$70.39 million and guidance for 2026 revenue of US$72 million to US$76 million. The quarter was heavily influenced by a large technology transfer agreement with Merck and growing ECO Synthesis platform activity, which also underpins management’s view that existing...

Several securities law firms have launched class action lawsuits against BellRing Brands (BRBR), accusing the company of misleading investors about what was driving its sales growth and how long that growth could last. See our latest analysis for BellRing Brands. Recent class action headlines are arriving after a sharp reset in expectations, with a 90 day share price return of 48.66% decline and a 1 year total shareholder return of 75.06% decline indicating that momentum has faded over both...

Loma Negra Compañía Industrial Argentina Sociedad Anónima has released its fourth quarter and full-year 2025 results, reporting AR$225,233 million in Q4 sales and AR$6,245 million in net income, with full-year sales of AR$848,087 million and net income of AR$23,585 million, all lower than the prior year. Amid softer cement volumes, pressure on margins, and a steep drop in earnings per share, Loma Negra still pointed to a stronger concrete segment and ESG progress, including reduced CO₂...

In early March 2026, Capital One Financial agreed to a proposed class action settlement over its 360 Savings accounts, including a US$425.00 million Settlement Fund and a commitment to align future 360 Savings interest rates with its 360 Performance Savings product, subject to court approval. The case highlights how differences in interest paid on similar-looking products and alleged disclosure gaps can create substantial legal, financial, and reputational repercussions for a large consumer...

XP (XP) is in focus after two product launches in Brazil: a partnership with prediction market platform Kalshi and the rollout of USDXP, a US$ backed stablecoin issued via Clear Corretora. See our latest analysis for XP. XP's recent product launches come after a mixed period for the share price. A 30 day share price return of an 8.4% decline contrasts with a 12.5% share price gain year to date and a 25.3% 1 year total shareholder return, suggesting momentum has softened in the short term...

Sotera Health recently completed a follow-on equity offering of US$381.75 million, issuing 25,000,000 common shares at US$15.27 each, boosting its capital base but increasing its share count. This fresh equity capital gives Sotera Health more financial flexibility to fund growth projects or reduce debt, while shareholders weigh the impact of dilution. Next, we'll examine how this sizeable equity raise and resulting dilution could reshape Sotera Health's investment narrative going...

In March 2026, Marsh announced that Nick Studer will become President and CEO of Marsh Risk on April 1, 2026, succeeding Martin South, who moves into an enterprise-wide role as Chief Client Officer while both remain on the Executive Committee reporting to John Doyle. This leadership reshuffle strengthens Marsh’s focus on client impact and innovation, bringing Oliver Wyman’s consulting expertise closer to the core risk business while a new Oliver Wyman CEO is named. Next, we’ll examine how...

In recent weeks, CCM Hockey and Mattel announced the launch of an all-new Barbie x CCM Collection of performance hockey gear and apparel aimed at making the sport more inclusive and expressive for a new generation of girls and athletes. This collaboration highlights Mattel’s broader push to extend the Barbie brand beyond traditional toys into sports and lifestyle, aligning with its ambition to build a wider entertainment and consumer-products platform. We’ll now look at how this inclusive...

Simmons First National (NasdaqGS:SFNC) reported quarterly results that exceeded revenue and EPS expectations. The bank highlighted resilient operations and solid performance within its regional banking footprint. The update adds fresh information on the company’s current business momentum that has not been reflected in recent coverage. Simmons First National, trading at $18.61, has delivered a quarter that came in ahead of both revenue and earnings forecasts, which puts a fresh spotlight on...

This article examines whether Petco Health and Wellness Company, at around US$3.62, may represent a bargain or a value trap by exploring what the current share price might indicate about the business. The stock has recently experienced sharp moves, with returns of 52.1% over the last 7 days, 44.2% over the last 30 days, 27.0% year to date and 51.5% over the last year. However, the 3 year and 5 year returns show declines of 63.1% and 84.4%, which tells a very different story. These swings...

Old Republic International (NYSE:ORI) has appointed Doug Wordekemper as CEO of Old Republic Professional. The move is part of a broader organizational leadership change within the Professional division. The appointment brings a leader with extensive industry experience into a key role overseeing the Professional business. Old Republic International, through its Professional division, focuses on specialty insurance solutions for professional liability and related risks. Leadership changes in...

Subscriber milestone puts Karooooo (KARO) in focus Cartrack, a subsidiary of Karooooo (KARO), has surpassed two million active subscribers in South Africa. This milestone puts the group’s mobility SaaS model and customer-focused execution firmly on investors’ radar. See our latest analysis for Karooooo. Karooooo’s latest subscriber milestone lands after a period where the share price has moved steadily rather than sharply, with a 5.69% year to date share price return and a 19.93% one year...

If you are wondering whether WEX at around US$159.95 is priced fairly or offering value, you are not alone. This article is built to help you assess that question using several valuation tools. The stock has been relatively mixed recently, with a 7.8% return year to date and 3.8% over the last year, alongside a 4.3% decline over the past week and a 1.4% gain over the last 30 days. These movements can change how the market is thinking about its risk and opportunity. Recent coverage has...

Earlier this month, Jones Lang LaSalle unveiled its Accelerate 2030 plan, pairing new long-term financial targets with an enlarged share repurchase authorization of US$4.40 billion, including a US$200 million accelerated buyback. This combination of technology-led growth ambitions and a very large capital return commitment marks a meaningful shift in how JLL is positioning itself for clients and shareholders through 2030. Next, we’ll consider how JLL’s significantly expanded share buyback...

Setting the scene on U.S. Physical Therapy With no fresh headline event driving U.S. Physical Therapy (USPH) today, investors are left weighing a share price of $76.83 alongside recent return figures and the company’s latest reported revenue and net income. See our latest analysis for U.S. Physical Therapy. The recent share price pullback, including a 1-day share price return of 1.35% decline and a 30-day share price return of 11.63% decline, sits alongside a 1-year total shareholder return...

In recent months, Driehaus Capital Management and Deerfield Management Company have sharply increased their holdings in Praxis Precision Medicines, adding hundreds of thousands of shares and committing a combined investment of more than US$346.79 million as the company filed two FDA new drug applications for ulixacaltamide and relutrigine. This combination of larger institutional ownership, advancing late‑stage neuroscience candidates and a cash position supported by roughly US$1.55 billion...